Aguettant,
pharmaceutical company

Essential medicines are at the heart of healthcare systems. Ensuring their availability is a major public health challenge.

The Chief Executive Officer, Philippe de POUGNADORESSE, presents the Group's mission as follows:

For six generations, our Group has pursued a vital mission: to guarantee patients access to essential treatments, working alongside healthcare professionals, and to help improve the patient care journey. As an integrated pharmaceutical company and a specialist in injectable medicines, we control the entire value chain—from development and manufacturing to commercialization—all based in France. This expertise enables us to develop and produce essential medicines, including many Critical Medicines, serving hospitals and healthcare institutions. Deeply rooted in France and driven by a strong international ambition, Aguettant contributes to strengthening France's pharmaceutical sovereignty while accelerating its growth across global healthcare systems and promoting French healthcare expertise worldwide.

He concludes by highlighting the Group's commitment: combining scientific innovation, industrial excellence, and environmental responsibility to improve patient care pathways and sustainably meet the needs of both patients and healthcare professionals, concludes Philippe de POUGNADORESSE, Chief Executive Officer.